Osaic Holdings’s TriSalus Life Sciences TLSI Stock Holding History

Osaic Holdings’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-79	Closed	-$395	–	7704
2024 Q4	$395	Buy	+79	New	+$334	﹤0.01%	7071

Other funds holding TLSI

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings's TLSI Position: Q1 2025 in Review

Osaic Holdings sold out of TriSalus Life Sciences (TLSI) in Q1 2025, closing a stake of 79 shares — an estimated $395 sold.

Osaic Holdings first reported a position in TLSI in Q4 2024 and held it in 1 quarter. The position peaked at $395 in Q4 2024. 36 funds tracked by Wall St. Rank hold TLSI as of Q1 2025.

Osaic Holdings reported no remaining TriSalus Life Sciences position as of Q1 2025 after selling out during the quarter.
Osaic Holdings sold 79 TriSalus Life Sciences shares in Q1 2025, an estimated $395.
Osaic Holdings first reported a position in TriSalus Life Sciences in Q4 2024 and held it in 1 quarter.
Osaic Holdings's TriSalus Life Sciences position peaked at $395 in Q4 2024.
36 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.